ERBB2 and cancer: Other significant pathways include EGFR tyrosine kinase inhibitor resistance, cellular senescence, p53 pathway feedback loops 2, endometrial cancer, central carbon metabolism in cancer, microRNAs in cancer, the FoxO signaling pathway, and ErbB2/ErbB3 signaling events (Table 2).